カテゴリ： MarketLine, フランス, 企業調査

AccorHotels：戦略・SWOT・企業財務分析

◆英語タイトル：AccorHotels - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015228
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：60
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

AccorHotels – Strategy, SWOT and Corporate Finance Report
Summary

AccorHotels – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

AccorHotels (or ‘the group’) is a hotel operator. The group operates luxury to economy range hotels in Europe, the Americas, Asia Pacific, Mediterranean, Middle East and Africa. It is headquartered in Paris, France.

Scope

- Detailed information on AccorHotels required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AccorHotels in the form of a SWOT analysis
- An in-depth view of the business model of AccorHotels including a breakdown and examination of key business segments
- Intelligence on AccorHotels’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AccorHotels, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of AccorHotels and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AccorHotels as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on AccorHotels’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
AccorHotels: Company Overview
AccorHotels: Overview and Key Facts
AccorHotels: Overview
AccorHotels: Key Facts
AccorHotels: Key Employees
AccorHotels: Key Employee Biographies
AccorHotels: Major Products and Services
AccorHotels: Company History
AccorHotels: Management Statement
AccorHotels: Locations and Subsidiaries
AccorHotels: Key Competitors
AccorHotels: Company Analysis
AccorHotels: Business Description
AccorHotels: SWOT Analysis
AccorHotels: SWOT Overview
AccorHotels: Strengths
AccorHotels: Weaknesses
AccorHotels: Opportunities
AccorHotels: Threats
AccorHotels: Corporate Financial Deals Activity
AccorHotels: Financial Deals Overview
AccorHotels: Targets and Partners
AccorHotels: Top Deals 2013 – 2017YTD*
AccorHotels: Advisors
AccorHotels: Top Legal Advisors
AccorHotels: Top Financial Advisors
AccorHotels: Mergers and Acquisitions
AccorHotels: Corporate Venturing
AccorHotels: Capital Raising
AccorHotels: Partnership
AccorHotels: Divestments
AccorHotels: Recent Developments
AccorHotels: News and Events Summary
AccorHotels: Business Expansion
AccorHotels: Corporate Governance
AccorHotels: Financial Performance
AccorHotels: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: AccorHotels: Key Facts
Table 2: AccorHotels: Key Employees
Table 3: AccorHotels: Locations and Subsidiaries
Table 4: AccorHotels: Key Competitors
Table 5: AccorHotels: Deal Activity by Deal Type - Volume (TTM*)
Table 6: AccorHotels: M&A Activity by Geography (TTM*)
Table 7: AccorHotels: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 8: AccorHotels: M&A Average Deal Size - Value (US$m)
Table 9: AccorHotels: Targets and Partners
Table 10: AccorHotels: Top Deals 2013 - 2017YTD*
Table 11: AccorHotels: Legal Advisor Ranking by Value (US$m)
Table 12: AccorHotels: Financial Advisor Ranking by Value (US$m)
Table 13: AccorHotels: M&A Volume and Value Trend (2013 - YTD*2017)
Table 14: AccorHotels: M&A Activity by Geography (2013 - YTD*2017)
Table 15: AccorHotels: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 16: AccorHotels: Corporate Venturing by Geography (2013 - YTD*2017)
Table 17: AccorHotels: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 18: AccorHotels: Capital Raising by Deal Type (2013 - YTD*2017)
Table 19: AccorHotels: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 20: AccorHotels: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 21: AccorHotels: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 22: AccorHotels: Divestments by Geography (2013 - YTD*2017)
Table 23: AccorHotels: News and Events Summary
Table 24: AccorHotels: Business Expansion
Table 25: AccorHotels: Corporate Governance
Table 26: AccorHotels: Financial Performance
Table 27: AccorHotels: Strategy and Operations

★海外企業調査レポート[AccorHotels：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Electronic Arts Inc.：企業の戦略・SWOT・財務情報
    Electronic Arts Inc. - Strategy, SWOT and Corporate Finance Report Summary Electronic Arts Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Elasmogen Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Elasmogen Ltd (Elasmogen), formerly Pacific Shelf 1760 Ltd is a biopharmaceutical company that discovers and develops sight-saving therapies for the treatment of inflammatory diseases of the eye and inflammatory conditions of the gut. The company develops soloMER that are small (11 kDa) and …
  • Dermapharm AG-製薬・医療分野：企業M&A・提携分析
    Summary Dermapharm AG (Dermapharm) is a pharmaceutical company that offers dermatological and allergy medicines. The company provides products for allergies, disinfection and wound treatment, skin and hair care, corticoids, minerals, osteoporosis, fungal infections, vaginal thrush, other preparation …
  • Celixir Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Celixir Ltd (CTL), formerly Cell Therapy Ltd is a biotechnology company that discovers and develops regenerative medicines using adult stem cells for the treatment of heart failure. The company provids heartcel which is a type of stem cell therapy that provides improved outcomes for end-stag …
  • Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)-医療機器分野：企業M&A・提携分析
    Summary Jiangsu Yuyue Medical Equipment & Supply Co Ltd (Jiangsu Yuyue) is a medical device company that manufactures and distributes various medical equipments. The company’s products include electronic blood pressure monitor, air sterilization purifier, X-ray machine, blood glucose meter, temperat …
  • Pernod Ricard SA：企業の戦略・SWOT・財務情報
    Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report Summary Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vericel Corp (VCEL)-医療機器分野：企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • ANGLE Plc (AGL)：製薬・医療：M&Aディール及び事業提携情報
    Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of …
  • Inchcape plc：企業の戦略・SWOT・財務分析
    Inchcape plc - Strategy, SWOT and Corporate Finance Report Summary Inchcape plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Yamana Gold Inc.
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • AdvanDx Inc：医療機器：M&Aディール及び事業提携情報
    Summary AdvanDx Inc (AdvanDx), a subsidiary of OpGen Inc is a healthcare solution provider that offers rapid and accurate molecular diagnostic tests for identification of pathogens causing critical infections in hospitalized patients. The company operates molecular testing of positive blood cultures …
  • Bioasis Technologies Inc (BTI)：医療機器：M&Aディール及び事業提携情報
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • Natrix Separations Inc-製薬・医療分野：企業M&A・提携分析
    Summary Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies is a medical device company that provides disposable products. The company’s products line comprise HD-Q membrane adsorbers and bind-elute products. Its HD-Q membrane adsorbers finds application in single-use flow-through p …
  • Sime Darby Berhad：戦略・SWOT・企業財務分析
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • NetSuite Inc：企業の戦略的SWOT分析
    NetSuite Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tullow Oil plc：企業の戦略・SWOT・財務分析
    Tullow Oil plc - Strategy, SWOT and Corporate Finance Report Summary Tullow Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Avangrid Inc (AGR)：企業の財務・戦略的SWOT分析
    Avangrid Inc (AGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nippon Chemiphar Co Ltd (4539)：企業の財務・戦略的SWOT分析
    Summary Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. It offers diagnostic products, such as IgE NC, a diagnostic kit that provides r …
  • Eizo Corp (6737)：企業の財務・戦略的SWOT分析
    Eizo Corp (6737) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Saudi Cable Company (2110)：企業の財務・戦略的SWOT分析
    Saudi Cable Company (2110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆